Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
/afaqs/media/media_files/2026/02/18/pawan-main-2026-02-18-22-45-58.png)
This is uncomfortable for pharma marketers. But future is reality
I recently launched our second book, A Handbook of Artificial Intelligence (AI) in Electronic Health Records (EHRs), at the Conferences of Cardiologists, Nephrologists, Paediatricians, and Sexologists. Many doctors came up to me at my company…
Conventional financing remains a hurdle for pharma innovation, say industry leaders
India has the potential to move up the pharmaceutical value chain from its existing dominant position as a major generics manufacturer globally to a big player in innovation, particularly drug discovery, if such efforts are supported by adequate…
Telangana will build future-ready ecosystem for pharma, biotech industry: Sridhar Babu
Telangana is committed to building a future-ready ecosystem that translates scientific breakthroughs into practical healthcare solutions, D Sridhar Babu, Telangana Minister for IT and Industries said. Speaking at the valedictory session of the 23…
The art of the deal: what are Trump's pharma announcements really worth?
On October 10, the White House announced a deal between the United States and the British pharma giant, AstraZeneca, that included a $50 billion (CHF38.8 billion) investment in the US and the creation of 3,600 jobs. The press release also mentioned…
LEO Pharma Positions for IPO This Year With Investor Meetings
LEO Pharma A/S's leadership has been engaging prospective investors in recent months as it advances preparations for a potential stock market listing this year, Chief Executive Officer Christophe Bourdon said. The Danish drugmaker, which focuses on…
Zealand Pharma announces positive Phase 1a topline results with Kv1.3 channel blocker ZP9830
Press release – No. 4 / 2026 Zealand Pharma announces positive Phase 1a topline results with Kv1.3 channel blocker ZP9830 Single doses of ZP9830 were well tolerated, with no serious or severe adverse events or dose-limiting safety findings…
Trump officials try to make peace with pharma
Senior Trump administration health officials sought to smooth over simmering tensions with the drug industry at an industry forum on Tuesday — but with limited success. Why it matters: Drug companies have been frustrated navigating President…
AI in pharma sector
With rising manufacturing complexity and intensified regulatory expectations, traditional quality frameworks are no longer sufficient for Indian pharmaceutical industry. Emerging technologies such as artificial intelligence (AI) is now emerging as…
Starget Pharma secures $18M, launches cancer therapy collaboration in Shreveport
SHREVEPORT, La. — A clinical-stage radiopharmaceutical company announced a new funding round and partnership aimed at accelerating development of next-generation cancer therapies while expanding Louisiana's life sciences footprint. Starget…
Pharma, life sciences GCCs cut drug development timelines, costs: Report
India's Pharma and Life Sciences Global Capability Centres (GCCs) cut drug development timelines by one to two years and drive a 5 per cent decline in R&D to launch costs, according to a KPMG India and UnearthIQ Report. According to the report…
BridgeBio Pharma (NASDAQ:BBIO) CAO Maricel Apuli Sells 510 Shares
BridgeBio Pharma, Inc. (NASDAQ:BBIO - Get Free Report) CAO Maricel Apuli sold 510 shares of the business's stock in a transaction on Tuesday, February 17th. The stock was sold at an average price of $74.31, for a total value of $37,898.10.
Dr Reddy's buys progynova, cyclo-progynova brands for Indian market from Mercury Pharma for $32 million
Dr. Reddy's Laboratories has acquired the trademarks of specialty brands, Progynova and Cyclo-Progynova, and related assets, for India from Mercury Pharma Group, a UK-headquartered specialty pharmaceutical company for $32.15 million Progynova…
BridgeBio Pharma (NASDAQ:BBIO) Director Randal Scott Sells 10,000 Shares
BridgeBio Pharma, Inc. (NASDAQ:BBIO - Get Free Report) Director Randal Scott sold 10,000 shares of the company's stock in a transaction that occurred on Tuesday, February 17th. The shares were sold at an average price of $75.46, for a total value…
Insider Selling: BridgeBio Pharma (NASDAQ:BBIO) CFO Sells 13,600 Shares of Stock
BridgeBio Pharma, Inc. (NASDAQ:BBIO - Get Free Report) CFO Thomas Trimarchi sold 13,600 shares of the company's stock in a transaction dated Tuesday, February 17th. The shares were sold at an average price of $74.72, for a total value of…
Pharma GCCs are leveraging AI to cut drug development timelines by 4-6 years, says report
Pharmaceuticals and Life Sciences Global Capability Centres (GCCs) are leveraging AI and advanced analytics to reduce drug development timelines from 10–15 years to 9–13 years, according to a report by KPMG and UnearthIQ. These GCCs…
Receive a Daily briefing on Pharma Industry News
Get Started